Abstract
Aim:
To describe the clinical course of a young woman who developed vestibulodynia with introital dyspareunia while on oral contraceptive (OCs) and to provide a possible explanation for the etiology of her symptoms as well as her recovery after treatment.
Methods:
A single case is presented including subjective reporting, laboratory evaluation, and quantitative sensory testing.
Results:
After topical hormonal therapy, the patient reported resolution of her dyspareunia and and her laboratory values normalized.
Publication types
-
Case Reports
-
Research Support, Non-U.S. Gov't
MeSH terms
-
Administration, Intravaginal
-
Adult
-
Coitus
-
Dyspareunia / blood
-
Dyspareunia / chemically induced
-
Dyspareunia / diagnosis
-
Dyspareunia / drug therapy
-
Estradiol / administration & dosage
-
Estradiol / blood
-
Female
-
Humans
-
Reproductive Control Agents / administration & dosage
-
Reproductive Control Agents / adverse effects*
-
Sex Hormone-Binding Globulin / metabolism
-
Testosterone / administration & dosage
-
Testosterone / blood
-
Vulvodynia / blood
-
Vulvodynia / chemically induced*
-
Vulvodynia / diagnosis
-
Vulvodynia / drug therapy
Substances
-
Reproductive Control Agents
-
Sex Hormone-Binding Globulin
-
Testosterone
-
Estradiol